This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

10 Stocks That Could Rise in Market Decline

10. Baker Hughes (BHI)

Company profile: Baker Hughes, with a market value of $18 billion, is a provider of a wide variety of oil-field services, such as directional drilling, oil field chemicals, drill bits, and electronic submersible pumping systems.

Dividend Yield: 1.4%

Investor takeaway: Its shares are down 15% this year, but have a three-year, average annual return of 11%. Analysts give its shares 13 "buy" ratings, nine "buy/holds," 11 "holds," and one "weak hold," according to a survey of analysts by S&P. Morningstar says its shares, now trading at $40.59, are trading at 46% of their fair-value estimate of $86.

9. AMN Healthcare Services (AHS)

Company profile: AMN Healthcare, with a market value of $248 million, is the largest health-care staffing firm in the U.S. About two-thirds of its business is generated from its temporary nursing division, but it also provides medical professionals of all ranks.

Investor takeaway: Its shares are up 41% this year, including 22% in the past month, and have a three-year, average annual return of 1%. Analysts give its shares three "buy" ratings and four "holds," according to a survey of analysts by S&P. Morningstar analyst Vishnu Lekraj says the company is in place to benefit long-term, from strong secular industry tailwinds. Morningstar says the shares, recently at $5.90, are trading at 45% of their fair-value estimate of $13.

8. Halliburton (HAL)

Company profile: Halliburton, with a market value of $30 billion, provides a variety of oil-field services, from pressure pumping to drilling, across North America and about 80 countries.

Dividend Yield: 1.1%

Investor takeaway: Its shares are down 4.8% this year, but have a three-year, average annual return of 25%. Morningstar says its shares, now trading at $32.37, are trading at 45% of their fair-value estimate of $72. Analysts tracked by S&P give its shares 16 "buy" ratings, 13 "buy/holds," and four "holds," according to a survey of analysts by S&P.

7. GenOn Energy (GEN)

Company profile: GenOn Energy, with a market value of $1.5 billion, is an independent power producer operating in the Mid-Atlantic and Northeast regions and also in California. The company was formed by the result of the December, 2010 merger of RRI Energy and Mirant.

Investor takeaway: Its shares are down 22% this year and have a three-year, average annual loss of 19%. Morningstar says that its shares, now trading at $2, are trading at 44% of fair value of $4.50. Analysts give its shares five "buy" ratings, one "buy/holds," three "holds," and three "sells," according to a survey of analysts by S&P. S&P, which has it rated "buy" says the merger will result in geographic diversity and reduces its reliance on coal-fired assets.

6. Exelixis (EXEL)

Company profile: Exelixis, with a market value of $754 million, is development-stage biotechnology company with a focus on therapeutics for the treatment of cancer and other serious diseases.

Investor takeaway: Its shares are up 7.3% this year and have a three-year, average annual return of 1.5%. Morningstar says its shares, now at $4.94, are trading at 44% of its fair-value estimate of $11. Analysts give its shares three "buy" ratings, one "buy/hold," and six "holds," according to a survey of analysts by S&P.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs